Isoxazole Moiety in the Linker Region of HDAC Inhibitors Adjacent to the Zn-Chelating Group: Effects on HDAC Biology and Antiproliferative Activity

Bioorganic and Medicinal Chemistry Letters - United Kingdom
doi 10.1016/j.bmcl.2009.04.058
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Effects of Novel HDAC Inhibitors on Urothelial Carcinoma Cells

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2018English

HSP72 Functionally Inhibits the Anti-Neoplastic Effects of HDAC Inhibitors

Journal of Dermatological Science
DermatologyBiochemistryMolecular Biology
2018English

Synthesis and Antiproliferative Assay of Triazolyl-2,2-Dimethyl-3-Phenylpropanoates as Potential HDAC Inhibitors

RSC Advances
ChemistryChemical Engineering
2019English

Identification of HDAC Inhibitors Using a Cell-Based HDAC I/Ii Assay

Journal of Biomolecular Screening
Molecular MedicinePharmacologyBiochemistryAnalytical ChemistryBiotechnologyDrug Discovery
2016English

Comparison of HDAC Inhibitors in Clinical Development

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

HDAC Inhibitors in Experimental Liver and Kidney Fibrosis

Fibrogenesis and Tissue Repair
DermatologyMedicineHepatologyRheumatologyGastroenterology
2013English

Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel in Vitro and in Vivo

PLoS ONE
Multidisciplinary
2011English

HDAC Inhibitors Show Benefits in Breast Cancer

Cancer Discovery
Oncology
2011English

HDAC Inhibitors Enhance the Immunotherapy Response of Melanoma Cells

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy